Journal Information
Vol. 54. Issue 6.
Pages 313-319 (June 2018)
Share
Share
Download PDF
More article options
ePub
Visits
...
Vol. 54. Issue 6.
Pages 313-319 (June 2018)
Original Article
Lung Transplantation in Cystic Fibrosis and the Impact of Extracorporeal Circulation
El trasplante pulmonar en la fibrosis quística y la influencia de la circulación extracorpórea
Visits
4581
Alberto Jaureguia,
Corresponding author
ajauregui@vhebron.net

Corresponding author.
, Maria Deua, Laura Romeroa, Antonio Romanb, Antonio Morenoc, Manuel Armengold, Juan Soléa
a Servicio de Cirugía Torácica, Hospital Universitario Vall d’Hebron, Barcelona, Spain
b Servicio de Neumología, Hospital Universitario Vall d’Hebron, Barcelona, Spain
c Servicio de Neumología Pediátrica, Hospital Universitario Vall d’Hebron, Barcelona, Spain
d Servicio de Cirugía General, Hospital Universitario Vall d’Hebron, Barcelona, Spain
Podcast
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (6)
Show moreShow less
Tables (5)
Table 1. Univariate Analysis of Risk Factors for Mortality According to the Cox Proportional Hazards Method.
Table 2. Actuarial Survival by Different Nutritional Grades.
Table 3. Comparison of Pulmonary functions test by need of ECC.
Table 4. Univariate Analysis of Risk Factors for ECC According to the Cox Proportional Hazards Method.
Table 5. Multivariate Analysis of ECC Risk Factors. Final Cox's Proportional Hazards Regression Model With Statistically Significant Variables in the Univariate Analysis.
Show moreShow less
Additional material (1)
Abstract
Introduction

Lung disease is the major cause of death among cystic fibrosis (CF) patients, affecting 80% of the population. The impact of extracorporeal circulation (ECC) during transplantation has not been fully clarified. This study aimed to evaluate the outcomes of lung transplantation for CF in a single center, and to assess the impact of ECC on survival.

Methods

We performed a retrospective observational study of all transplanted CF patients in a single center between 1992 and 2011. During this period, 64 lung transplantations for CF were performed.

Results

Five- and 10-year survival of transplanted patients was 56.7% and 41.3%, respectively. Pre-transplantation supplemental oxygen requirements and non-invasive mechanical ventilation (NIMV) do not seem to affect survival (P=.44 and P=.63, respectively). Five- and 10-year survival among patients who did not undergo ECC during transplantation was 75.69% and 49.06%, respectively, while in those did undergo ECC during the procedure, 5- and 10-year survival was 34.14% and 29.87%, respectively (P=.001). PaCO2 is an independent risk factor for the need for ECC.

Conclusions

The survival rates of CF patients undergoing lung transplantation in our hospital are similar to those described in international registries. Survival is lower among patients receiving ECC during the procedure. PaCO2 is a risk factor for the need for ECC during lung transplantation.

Keywords:
Cystic fibrosis
Lung transplantation
Extracorporeal circulation
Resumen
Introducción

La enfermedad pulmonar es la principal causa de mortalidad en el 80% de los pacientes con fibrosis quística (FQ). La influencia de la circulación extracorpórea (CEC) no está completamente establecida. Los objetivos son evaluar los resultados del trasplante pulmonar por FQ en un solo centro y la influencia de la CEC sobre la supervivencia de estos pacientes.

Métodos

Estudio observacional retrospectivo de todos los pacientes afectados de FQ trasplantados en un solo centro entre 1992 y 2011. En este período se han realizado 64 trasplantes pulmonares por FQ.

Resultados

La supervivencia de los pacientes trasplantados a los 5 y 10 años fue del 56,7 y el 41,3%, respectivamente. El requerimiento de oxígeno suplementario previo al trasplante no parece afectar a la supervivencia (p=0,44), al igual que los pacientes que se trasplantaron con ventilación mecánica no invasiva (p=0,63). La supervivencia a los 5 y 10 años para los pacientes que no se trasplantan con CEC es del 75,69 y el 49,06%, respectivamente, mientras que los que se trasplantan bajo CEC tienen un supervivencia a los 5 y 10 años del 34,14 y el 29,87%, respectivamente (p=0,001). La PaCO2 es un factor de riesgo independiente para la necesidad de CEC.

Conclusiones

Los pacientes con FQ trasplantados pulmonares en nuestro centro tiene una supervivencia similar a la descrita por los registros internacionales. Los pacientes trasplantados bajo CEC tienen una menor supervivencia. La PaCO2 es factor de riesgo de necesidad de CEC durante el trasplante pulmonar.

Palabras clave:
Fibrosis quística
Trasplante pulmonar
Circulación extracorpórea

Article

These are the options to access the full texts of the publication Archivos de Bronconeumología
Member
Si es usted socio de la SEPAR siga los siguientes pasos:
  • Diríjase desde aquí a la web de la >>>SEPAR<<< e inicie sesión mediante el formulario que se encuentra en la barra lateral derecha de la web de la sociedad.
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Archivos de Bronconeumología

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
Email
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?